ftInvstr
BROOKS · Healthcare ₹66.0 +2.87% Mkt Cap ₹194 Cr

BROOKS

Healthcare Drug Manufacturers - Specialty & Generic
₹66.0
+2.87% today · 30d +9.09%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for BROOKS. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹23 Cr
-10.0% YoY
NET PROFIT
₹-2 Cr
-118.64% YoY
OPM
8.81%
-4.18pp YoY
EPS
₹-0.61
PE 15.08
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-50.0%, h2=-50.0%, h3=-50.0% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
BROOKS15.08-10.0
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
50
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 5
Valuation CHEAP 75
Growth MUTED 46
Profitability AVERAGE 30
Technicals NEUTRAL 65
Risk LOW 80
Key Stats
TTM PE
15.08
P/B
1.63
52W HIGH
₹163.9
OFF HIGH
-59.73%
MKT CAP
₹194 Cr
◉ Active Signals
MACDBullish0.6012
RSI(14)Neutral56.27
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold BROOKS and at what entry.

Sign up freeSign in